Jennifer Bushre
Family · Bolivar, MONPI 1811712623
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations.
Across 143 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$309
- Merck$269
- AstraZeneca$260
- Novartis$257
- Regeneron Healthcare Solutions, Inc.$204
- Daiichi Sankyo Inc.$200
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,06497%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 15 | $309 |
| Merck | 12 | $269 |
| AstraZeneca | 9 | $260 |
| Novartis | 13 | $257 |
| Regeneron Healthcare Solutions, Inc. | 6 | $204 |
| Daiichi Sankyo Inc. | 6 | $200 |
| Stemline Therapeutics Inc. | 6 | $106 |
| Genentech USA, Inc. | 6 | $104 |
| Eisai Inc. | 6 | $104 |
| AbbVie | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| GSK | 4 | $78 |
| AVEO Pharmaceuticals, Inc. | 4 | $76 |
| Karyopharm Therapeutics Inc. | 3 | $74 |
| Dendreon Pharmaceuticals LLC | 3 | $71 |
| Gilead | 3 | $68 |
| Bayer | 3 | $64 |
| Boehringer Ingelheim | 2 | $57 |
| Bristol Myers Squibb | 3 | $57 |
| Incyte Corporation | 3 | $56 |
| Pfizer | 3 | $56 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $54 |
| Caris MPI, Inc. | 2 | $51 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Sobi, Inc | 2 | $43 |
| Genmab U.S., Inc. | 2 | $41 |
| Sanofi | 2 | $41 |
| Exelixis Inc. | 2 | $37 |
| Recordati_rare_diseases_inc. | 1 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Syndax Pharmaceuticals, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $14 |
How this compares
$3,163 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Other family in Bolivar
- Bailey ShunyakovBolivar$27K
- Bethany MartinBolivar$17K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.